Publicaties

Geuijen P, de Rond M, Kuppens J, Atsma F, Schene A, de Haan H, de Jong C, Schellekens A.  2020.  Physicians' norms and attitudes towards substance use in colleague physicians: A cross-sectional survey in the Netherlands. PLoS One. 15(4):e0231084.

de Jong LAA, Qurishi R, Stams MPJ, Böttcher M, De Jong CAJ.  2020.  Prolonged Ketamine and Norketamine Excretion Profiles in Urine After Chronic Use: A Case Series.. J Clin Psychopharmacol. 40(3):300-304.

de Jong CAJ, de Jong-Verhagen JG, Pols R., Verbrugge CAG, Baldacchino A.  2020.  Psychological Impact of the Acute COVID-19 Period on Patients With Substance Use Disorders: We Are All in This Together.. Basic and Clinical Neuroscience, 11(3.Covid19), 163-172. http://dx.doi.org/10.32598/bcn.11.covid19.2543.1. 6 June (Special Issue on Covid-19)

DeJong CAJ, Verhagen JGDeJong, Pols R, Verbrugge CAG, Baldacchino A.  2020.  Psychological Impact of the Acute COVID-19 Period on Patients With Substance Use Disorders: We are all in this Together.. Basic Clin Neurosci. 11(2):207-216.

Soe-Agnie SE, Paap MCS, Nijman HLI, De Jong CAJ.  2020.  Psychometric Properties of the Externalizing Spectrum Inventory: Replication and Extension across Clinical and Non-Clinical Samples.. J Pers Assess. :1-10.

Bruijnen CJWH, Dijkstra BAG, Walvoort SJW, Budy MJJ, Beurmanjer H, de Jong CAJ, Kessels RPC.  2020.  Psychometric properties of the Montreal Cognitive Assessment (MoCA) in healthy participants aged 18-70.. Int J Psychiatry Clin Pract. :1-8.

Ebenau A, Dijkstra BAG, Huurne CTer, Hasselaar J, Vissers K, Groot M.  2019.  Palliative care for people with substance use disorder and multiple problems: a qualitative study on experiences of patients and proxies. BMC Palliat Care. 18(1):56.

Bruijnen CJWH, Dijkstra BAG, Walvoort SJW, Markus W, VanDerNagel JEL, Kessels RPC, de Jong CAJ.  2019.  Prevalence of cognitive impairment in patients with substance use disorder. The Authors Drug and Alcohol Review .

Bruijnen CJWH, Dijkstra BAG, Walvoort SJW, Markus W, VanDerNagel JEL, Kessels RPC, DeJong CAJ.  2019.  Prevalence of cognitive impairment in patients with substance use disorder. Drug Alcohol Rev. 38(4):435-442.

VanDerNagel JEL, Duijvenbode vanN, Ruedrich S., Ayu A.P., Schellekens A.F.A..  2018.  The Perception of Substance Use Disorder Among Clinicians, Caregivers and Family Members of Individuals With Intellectual and Developmental Disabilities. Journal of mental health research in intellectual disabilities. 11:54-68.

Kamal RM, Dijkstra BAG, van Oene GH de Weert, van Duren JAM, DeJong CA.  2016.  Psychiatric Comorbidity, Psychological Distress and Quality of Life in Gamma-hydroxybutyrate (GHB) Dependent Patients.. J Addict Dis.

Paling E.P., Dijkstra BAG, DeJong CA, Schellekens A.  2015.  Prevalentie en behandeling van benzodiazepineverslaving. Tijdschrift Gedragstherapie. 48(2):185-198.

Merkx M.JM, De Fuentes-Merillas L, Wanningen J., van Emmerik C..  2014.  Protocol: Contingency management gecombineerd met een CGT-interventie voor middelengebruik.

Qurishi R, Sonneborn C, de Jong-Arts M, DeJong CA.  2013.  Premenstrual syndrome and self-medication with opioids.. J Addict Med. 7(1):79-82.

Dijkstra BAG, Roozen HG.  2012.  Patients' Improvements Measured With the Pleasant Activities List and the Community Reinforcement Approach Happiness Scale: Preliminary Results. Addictive Disorders & Their Treatment. 11(1)

Iskandar S, Kamal RM, DeJong CA.  2012.  Psychiatric comorbidity in injecting drug users in Asia and Africa.. Curr Opin Psychiatry. 25(3):213-8.

VanDerNagel JEl.  2012.  Psychiatrische stoornissen bij Verstandelijk Gehandicapten. Psychiatrie, serie Basiswerken .

Schellekens A, Mulder SF, van Eijndhoven PFP, Smilde TJ, van Herpen CML.  2011.  Psychotic symptoms in the course of sunitinib treatment for advanced renal cell cancer. Two cases.. Gen Hosp Psychiatry. 33(1):83.e1-3.

Iskandar S, Van Crevel R, Siregar IMP, Achmad TH, van der Ven AJAM, DeJong CA.  2009.  Prevention and Treatment of HIV Addicted Patients: a BioPsychoSocial Approach. Acta Med Indones-Indones J Int Med. S1(41):44.

Carpentier PJ, Krabbe PFM, Van Gogh MT, Knapen LJM, Buitelaar JK, DeJong CA.  2009.  Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. American Journal of Addiction. 6(18):80.

Dijkstra BAG, Krabbe PFM, Riezebos TGM, van der Staak CPF, DeJong CA.  2007.  Psychometric evaluation of the Dutch version of the Subjective Opiate Withdrawal Scale (SOWS).. Eur Addict Res. 13(2):81-8.

DeJong CA, van den Brink W, Harteveld FM, van der Wielen EG.  1993.  Personality disorders in alcoholics and drug addicts.. Compr Psychiatry. 34(2):87-94.